Horizon Therapeutics Public Limited Company's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2023 to a ratio of 5.47, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2023. Average collection period, for Horizon Therapeutics Public Limited's accounts receivable remained unchanged at 67 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 327 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2456, from overall ranking in the first quarter 2023 at 2679.

What is Receivable Turnover Ratio?
What is Horizon Therapeutics Public Limited Company Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HZNP Receivables Turnover Ratio	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Receivable Change	6.55 %	-8.74 %	6.89 %	-16.64 %	-8.45 %
Y / Y Revenue Change	7.71 %	-6.01 %	-7.14 %	-10.77 %	5.27 %
Receivable Turnover Ratio (TTM)	5.47	5.46	5.42	5.61	5.51
HZNP's Total Ranking	# 2456	# 2679	# 2449	# 2679	# 2449
Accounts Receivable average collection period days	67	67	67	65	66
Seq. Receivable Change	14.84 %	-7.64 %	4.64 %	-4 %	-1.64 %
Seq. Revenue Change	13.45 %	-11.67 %	1.8 %	5.59 %	-1 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 96
Healthcare Sector	# 328
Overall Market	# 2456

Receivable Turnover Ratio Statistics
High	Average	Low
0.9	0.38	0.25
(June 30. 2014)		(June 30. 2015)

HZNP Company Profile • Back to HZNP Efficiency Comparisons • Compare HZNP Receivables Turnover Ratio to its Competitors

Financial Statements
Horizon Therapeutics Public Limited's Accounts Receivable	$ 717 Millions	Visit HZNP's Balance sheet
Horizon Therapeutics Public Limited's Sales TTM	$ 3,643 Millions	Visit HZNP's Income Statement
Sources of HZNP's Revenues		Visit HZNP's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
HZNP's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
HZNP's Growth Rates	HZNP's Roa	HZNP's Inventory Turnover Ratio	HZNP's Dividend Comparisons
HZNP's Profitability Ratios	HZNP's Roi	HZNP's Asset Turnover Ratio	HZNP's Dividend Growth
HZNP's Valuation Ratios	HZNP's Roe	HZNP's Financial Strength Ratios	HZNP's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2023	Receivable at quarter ending Jun 30 2023
Arrowhead Pharmaceuticals Inc	13.94	$ 256.213 Millions	$ 18.375 Millions
23andme Holding Co	13.80	$ 295.656 Millions	$ 21.428 Millions
Neptune Wellness Solutions Inc	13.72	$ 46.971 Millions	$ 3.423 Millions
Corcept Therapeutics Inc	13.64	$ 428.153 Millions	$ 31.395 Millions
Revance Therapeutics Inc	13.44	$ 186.401 Millions	$ 13.872 Millions
Lifeloc Technologies Inc	13.25	$ 8.586 Millions	$ 0.648 Millions
Talkspace Inc	13.11	$ 128.554 Millions	$ 9.803 Millions
Plus Therapeutics Inc	13.07	$ 2.584 Millions	$ 0.198 Millions
Exact Sciences Corporation	12.96	$ 2,297.345 Millions	$ 177.234 Millions
International Stem Cell Corporation	12.77	$ 8.060 Millions	$ 0.631 Millions
Travere Therapeutics Inc	12.69	$ 226.054 Millions	$ 17.813 Millions
Marizyme Inc	12.67	$ 0.485 Millions	$ 0.038 Millions
Catalyst Pharmaceuticals Inc	12.63	$ 302.949 Millions	$ 23.994 Millions
Icu Medical Inc	12.46	$ 2,292.847 Millions	$ 184.062 Millions
Strata Critical Medical Inc	12.44	$ 190.117 Millions	$ 15.284 Millions
Vbi Vaccines Inc	12.39	$ 1.815 Millions	$ 0.147 Millions
Eton Pharmaceuticals Inc	12.33	$ 28.703 Millions	$ 2.327 Millions
Scienture Holdings Inc	12.14	$ 9.443 Millions	$ 0.778 Millions
Zomedica Corp	12.04	$ 21.463 Millions	$ 1.783 Millions
Teladoc Health Inc	12.00	$ 2,530.761 Millions	$ 210.854 Millions
Intellia Therapeutics Inc	11.95	$ 53.039 Millions	$ 4.438 Millions
Rockwell Medical inc	11.93	$ 74.722 Millions	$ 6.265 Millions
Emmaus Life Sciences Inc	11.77	$ 28.381 Millions	$ 2.411 Millions
Precipio inc	11.74	$ 10.956 Millions	$ 0.933 Millions
Lipocine Inc	11.73	$ 0.541 Millions	$ 0.046 Millions
Amylyx Pharmaceuticals Inc	11.55	$ 191.874 Millions	$ 16.618 Millions
Integrated Biopharma Inc	11.50	$ 50.061 Millions	$ 4.353 Millions
Zymeworks Inc	11.49	$ 447.704 Millions	$ 38.966 Millions
Milestone Scientific Inc	11.41	$ 9.944 Millions	$ 0.872 Millions
Avita Medical Inc	11.31	$ 40.850 Millions	$ 3.612 Millions

Date modified: 2026-09-08T15:22:11+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.